Compliance News

Parenteral Packaging Advances

Manufacturers of parenteral drugs face many challenges, particularly in light of the expanding population of more sensitive biopharmaceuticals. With smaller batch sizes and a need to control particulates and extractables and leachables, the industry … Read More

Supply Chain Partners Address Particulates

With attention from FDA and other regulatory agencies focused on visible particulates in parenteral drug products, the industry is actively working to find a solution. The problem is especially difficult to control because particulates can come from … Read More